Conakry

REUTERS   by Tom MIles                                                                     April 19, 2015

GENEVA--The World Health Organization has admitted serious failings in its handling of the Ebola crisis and pledged reforms to enable it to do better next time, its leadership said in a statement seen by Reuters on Sunday.

"We have learned lessons of humility. We have seen that old diseases in new contexts consistently spring new surprises," said the statement, attributed to the WHO Director-General Margaret Chan and the deputy director-general and regional directors.

"We have taken serious note of the criticisms of the Organization that, inter alia, the initial WHO response was slow and insufficient, we were not aggressive in alerting the world ... we did not work effectively in coordination with other partners, there were shortcomings in risk communications and there was confusion of roles and responsibilities...," it said.

The statement listed eight lessons learned, including areas where the WHO's response to Ebola could have been better, such as information sharing and communication....

Read complete story.

NEWSWEEK  by Conner Gaffey                               April 16, 2015
Diseases such as HIV and Ebola are on the verge of being diagnosed almost instantly using paper-based technology costing less than $1.

                                       Diseases may soon be tested for via paper and smartphones Getty

The devices, known as biosensing platforms, are made from cheap materials including plastic film and cellulose paper. Results are captured using a smartphone camera and sent back to hospitals or clinics for immediate diagnosis.

Current HIV diagnosis can cost up $48 (45) for a negative test and $64 (60) for a positive test. Checks for Ebola cost some $100 (95), take up to six hours to produce a result and require sophisticated diagnostic equipment, the type of which is often unavailable in western Africa where the disease is especially prevalent.

PLOS MEDICINE   by Ben Cooper and others                                                             April 14, 2015
Experimental treatments for Ebola virus disease might reduce EVD mortality. There is uncertainty about the ability of different clinical trial designs to identify effective treatments, and about the feasibility of implementing individually randomised controlled trials during an Ebola epidemic

A treatment evaluation programme for use in EVD was devised using a multi-stage approach (MSA) with two or three stages, including both non-randomised and randomised elements. The probabilities of rightly or wrongly recommending the experimental treatment, the required sample size, and the consequences for epidemic outcomes over 100 d under two epidemic scenarios were compared for the MSA, a sequential randomised controlled trial (SRCT) with up to 20 interim analyses, and, as a reference case, a conventional randomised controlled trial (RCT) without interim analyses.

Read complete study.

http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001815

UNITED NATIONS NEWS CENTRE                                                      April 16, 2015

WASHINGTON  --Intense efforts to control the Ebola outbreak in the three most-affected West African countries in will continue, the United Nations health chief said in Washington, DC today, adding that the international community is also looking for ways to build on dramatic recent progress by aiding with efforts aimed at recovery from the outbreak.

Tuesday 14 April 2015 was a happy day in Sierra Leone as children returned to school after many months             away, due to the Ebola outbreak. Photo: WHO/N. Alexander

“The goal is to help people and their communities to return to a normal life again,” said Margaret Chan, Director-General of the World Health Organization (WHO). “It means that children are going back to school, women can once again shop in their local markets, and livelihoods are restored.”